Receive our newsletter – data, insights and analysis delivered to you
September 11, 2011

St Jude neurostimulation device wins CE mark approval

St Jude Medical has received European CE mark approval for its Genesis neurostimulation device for peripheral nerve stimulation of the occipital nerves associated with intractable chronic migraine. The approval was backed by the 157-patient randomised, double-blind, controlled study, wh

By cms admin

St Jude Medical has received European CE mark approval for its Genesis neurostimulation device for peripheral nerve stimulation of the occipital nerves associated with intractable chronic migraine.

The approval was backed by the 157-patient randomised, double-blind, controlled study, which demonstrated that patients in the active group reported an average of seven fewer headache days a month as measured by the Migraine Disability Assessment questionnaire compared with only a one day per month decrease in the control (non-stimulation) group.

In addition, it is also found that there was showed a 41% improvement in overall disability in the active group after 12 weeks of stimulation, compared with a 13% improvement in the control group.

St Jude Medical neuromodulation division president Chris Chavez said that the CE mark was the first approval by a regulatory body for the use of neurostimulation to manage the debilitating symptoms of intractable chronic migraine.

”We will continue to work with regulatory authorities to secure approvals in order to offer this therapy option to patients throughout the world,” Chavez said.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU